Navigation Links
Governor's third business-plan contest kicks off

The Wisconsin Technology Council is taking applications for the 2006 governor's business-plan contest, in which entrepreneurs quite likely hundreds of them will vie for recognition and a $100,000 pot.

The last two years' grand-prize winners have been life-science companies, but finalists are also chosen in advanced manufacturing, business serv......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 12/07/05


Page: 1

Related biology technology :

1. Surgical products company wins Governors Business Plan Contest
2. MatriLab wins Governors Business Plan Contest
3. Tech Digest: President to honor WARF; plus, Governors tech-transfer award for entrepreneurs
4. Sound Focus plans to enter home-entertainment market after taking Governors prize
5. 27 finalists advance in Governors Business Plan Contest
6. Visions: Broderick says Wisconsin should be in top third in venture capital
7. Venture capital above $6B for third straight quarter
8. Third Wave reports $5.2M third quarter loss
9. U.S. risks third-world status in key technology
10. UW-Madison third in nation in tech-transfer value
11. VC funding increased in third quarter with shining life sciences

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Governor third business plan contest kicks off

(Date:12/2/2009)... Peregrine Pharmaceutica...n of patient enrollment in a dose confirmation and...relapsed glioblastoma multiforme (GBM), the deadli...noclonal antibody linked to a radioisotope being d...tara specifically targets cells at the center of b...
(Date:12/2/2009)...lands, December 2 Pepscan Holding ...cusing on protein mimicking,technology for the gen...t it,has appointed Wim E.M. Mol, Ph.D. as new Chie...sponsible for all of Pepscans corporate functions ... of the company. He brings to,Pepscan more than 20...
(Date:12/2/2009)...PRNewswire/ -- S*BIO Pte Ltd today announced data ...1518, at The American Society of Hematology 51st A... Data will be presented on the clinical results fr...ailing its safety, tolerability and pharmacokineti...anging from 100 to 600 mg. These doses were admini...
(Date:12/2/2009)...wswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ:...armaceutical company focused on endocrine therapy ...nd Drug Administration (FDA) has granted Fast Trac...nhibitor compound, perifosine (KRX-0401), for the ... Keryx Biopharmaceuticals, Inc. ("Keryx") ( KERX),...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...oNetwork are pleased to release the third in a se...t. , This third Podcast titled "Commercializatio...discussing the crucial issues around how nanotech... and translated into successful commercial outcome...) and podcast interviewee commented, "Nanotechnol...
...es,Corporation,s (OTC Bulletin Board: CNVT) holdin... from a customer in Beijing, China for a,Biofiltai...n) brings 2007,bookings from China to approximatel...rom China over the past 6 months., "We are please...ts,",said Peter Bruijns, President and CEO of BIOR...
...,Inc. (Nasdaq: RDEA ) today announced that its Pr...t, PharmD, will participate in the "In Search of t... Capital Markets 2007,Healthcare Conference on Wed... Westin Times Square Hotel in New York City. A liv...ussion will be accessible through Ardea,s,Investor...
Other Biology Technology:Commercialization of nanotechnology 2CVF Technologies Corporation's Holding - BIOREM Announces 3rd Order from China 2Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference 2Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference 3
(Date:12/2/2009)...RHAM, N.C. Duke University Medical Center researc...ant brain cancer glioma may be better able to resi...particular signaling pathway in these cancer stem ...ls with radiation in a laboratory experiment. , ... that cancer stem cells resist the effects of radi...
(Date:12/2/2009)...Scientists are reporting the first identification ...sformation that changes harmless marine bacteria i...udy appears in ACS, Environmental Science & Techn...d colleagues note that bleaching already has destr...and scientists are searching for ways to slow or s...
(Date:12/2/2009)...w York, NY, December 2, 2009 Commonly prescribed ...of asthma in pregnant women as well as pre-term la...disorders, psychiatric pathology, cognitive proble...according to a new study published in the December... & Gynecology . , Beta 2 adrenergic agonist drug...
Breaking Biology News(10 mins):Discovery makes brain tumor cells more responsive to radiation 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 1Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 2Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 3How to Protect Against the Swine Flu Virus 3A My Personal Experience with Gene Eden 28TM 29 a Broad Range Antiviral Supplement 55982 1How to Protect Against the Swine Flu Virus 3A My Personal Experience with Gene Eden 28TM 29 a Broad Range Antiviral Supplement 55982 2eCardio Included on Inc Magazines 28th Annual List of Americas Fastest Growing Private Companies the Inc 500 55980 1eCardio Included on Inc Magazines 28th Annual List of Americas Fastest Growing Private Companies the Inc 500 55980 2
...ll. (Sept. 3, 2008) Scientists at the U.S. Depart... have won an $800,000 EUREKA award from the Nation... precise molecular ruler for measuring distances w... Multi-wavelength Anomalous Diffraction using Medi... dramatically reduce the time necessary to reveal ...
..., Conn. Yale molecular and evolutionary biologists...ists produced the full genome sequence of Trichop... organisms, providing a new insight into the evolu...ed in the online edition of the journal Nature s...t nuclear genomes found in a multi-cellular creatu...
...ity, NY September 3, 2008 - The National Instit...fund 38 exceptionally innovative research projects...pact on many areas of science. The grants, from a ...entional Research Enabling Knowledge Acceleration)...onventional hypotheses or are pursuing major metho...
Other Biology News:NIH awards Argonne $800,000 to develop tool to measure distances within proteins 2Trichoplax genome sequenced -- 'rosetta stone' for understanding evolution 2NYU Cancer Institute researcher among first NIH EUREKA award recipients 2
...ervice provides the premium quality siRNAs you nee...can be readily ordered online by providing either ...e sense and antisense siRNA sequences. (Also check...designed siRNAs, which are already designed for yo...
Silencer In Vivo Ready siRNAs from Ambion
GEL FILTRATION CAL KIT HMW from GE Healthcare, formerly Amersham Biosciences
Goat Anti-Human TGF-beta RIIb Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: